Stockreport

Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]

Landos Biopharma, Inc.  (LABP) 
PDF NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos” or “the Company”), a clinical-stage biopharmaceutical company developing no [Read more]